Skip to main content
. 2023 Jan 4;13:1068978. doi: 10.3389/fimmu.2022.1068978

Figure 2.

Figure 2

(A, C) A baseline computed tomography scan taken before treatment with ICI therapy, demonstrating the left lung mass. (B, D) A computed tomography scan taken at the time of BP development (6 weeks after pembrolizumab discontinuation), showing a partial response.